AI-designed drug ISM5939 granted IND clearance for cancer clinical trials - News-Medical

Retrieved on: 2024-11-23 21:47:02

Tags for this article:

Click the tags to see associated articles and topics

AI-designed drug ISM5939 granted IND clearance for cancer clinical trials - News-Medical. View article details on hiswai:

Summary

The article discusses Insilico Medicine's advancements in generative AI for drug discovery, highlighting their new AI-driven cancer treatment ISM5939. This relates to the tags emphasizing AI's role in preclinical development and cybernetics within the company's strategy.

Article found on: www.news-medical.net

View Original Article